Pre-operative chemoterapy for squamos cell carcinoma of the oesophagus: Do histological assessment and p53 overexpression predict-chemo responsiveness

European Journal of Cancer Part A

Volumn 33, Issue 8, 1997, Pages 1221-1225

  Lam, K Y ^a   Law, S ^a   Ma, L T ^a   Ong, S K ^a   Wong, J ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Chemotherapy; Histology; Oesophageal carcinoma; p53

Indexed keywords

CISPLATIN; FLUOROURACIL; PROTEIN P53; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; DECISION MAKING; DIAGNOSTIC VALUE; ENDOSCOPIC BIOPSY; ESOPHAGUS CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; ADJUVANT CHEMOTHERAPY; ESOPHAGUS TUMOR; FEASIBILITY STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TREATMENT OUTCOME;

AGED; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030738995     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00094-4     Document Type: Article

References (19)

1. Lam KY, Ma LT, Wong J. Measurement of extent of spread of oesophageal squamous carcinoma by serial sectioning. J Clin Pathol 1996, 49, 124-129.
2. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: I A critical review of surgery. Br J Surg 1980, 67, 381-390.
3. Muller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990, 77, 845-857.
4. Kelen D. Neoadjuvant therapy of esophageal cancer. Can J Surg 1989, 32, 410-414.
5. Fink U, Stein HJ, Bochtler H, Roder JD, Wilke HJ, Siewert JR. Neoadjuvant therapy for squamous cell esophageal carcinoma. Ann Oncol 1994, 5, 517.
6. Hambraeus GM, Mercke CE, Willen R, et al. Prognostic factors influencing survival in combined radiotherapy and surgery of squamous cell carcinoma of the esophagus with special reference to a histopathologic grading system. Cancer 1988, 62, 895-904.
7. Lewinski T, Morysiñski T, Pietrow D, Sikora K. Preoperative radiotherapy combined with resection of squamous cell carcinoma of the mid-thoracic oesophagus. Does a histopathologic malignancy grading system assess actual survival? Eur J Surg Oncol 1991, 17, 571-574.
8. Lowe SW, Ruley HE, Jacks T, Houseman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993, 74, 957-967.
9. Harwood FG, Frazier MW, Krajewski S, Reed JC, Houghton JA. Acute and delayed apoptosis induced by thymidine deprivation correlates with expression of p53 and p53-regulated genes in colon carcinoma cells. Oncogene 1996, 12, 2057-2067.
10. Watanabe H, Jass JR, Sobin LH, in collaboration with pathologists in eight countries. Definition and explanatory notes. In World Health Organization International Histological Classification of Tumors: Histological Typing of Oesphagael and Gastric Tumours, 2nd edn. Berlin, Springer, 1990, 1-8.
11. Lam KY, Loke SL, Chen WZ, Cheung KN, Ma L. Expression of p53 in oesophageal squamous cell carcinoma in Hong Kong Chinese. Eur J Surg Oncol 1995, 21, 242-247.
12. Darnton SJ, Allen SM, Edwards CW, Matthews HR. Histopathologic findings in oesophageal carcinoma with and without preoperative chemotherapy. J Clin Pathol 1993, 46, 51-55.
13. Antonakopoulos GN, Darnton SJ, Newman J, Duffy JP, Matthews HR. Effect of chemotherapy on ultrastructure of oseophageal cell carcinoma. Histopathology 1994, 25, 447-454.
14. Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: clinicopathologic correlations. Cancer 1994, 73, 2680-2686.
15. Batsakis JG, El-Naggar AK. p53: Fifteen years after disco very. Adv Anat Pathol 1995, 2, 71-88.
16. Wynford-Thomas D. p53 In tumour pathology: can we trust immunocytometry? J Pathol 1992, 166, 329-330.
17. Hirai T, Kawano K, Hirabayashi N, et al. A novel in vitro chemosensitivity test using materials collected by endoscopie biopsy. Anticancer Drugs 1991, 2, 269-274.
18. Segalin A, Ruol A, Panozzo M, Bonavina L, Bianchi LC, Peracchia A. Flow cytometric DNA analysis does not predict the radiochemoresponsiveness of esophageal cancer. J Surg Oncol 1993, 54, 87-90.
19. Hickey K, Grehan D, Reid IM, O'Brian S, Walsh TN, Hennessy TP. Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy. Cancer 1994, 74, 1693-1698.